You are required to be logged in to access the full website
Click here if you have forgotten your username or password
26 July 2024 - Swedish research-based biopharma company BioArctic AB (STO:BIOA-B) and its partner Eisai Co Ltd (TYO:4523) announced on Friday that they intend to appeal the negative opinion on lecanemab for Alzheimer's disease from the Committee...
26 July 2024 - Biopharmaceutical company CStone Pharmaceuticals (HKEX:2616) on Friday announced European Commission approval of sugemalimab (Cejemly) in combination with platinum-based chemotherapy for first-line treatment of non-small cell lung canc...
26 July 2024 - Pharmaceutical research & development company AbbVie (NYSE:ABBV) on Friday announced European Commission approval for SKYRIZI (risankizumab) for the treatment of moderately to severely active ulcerative colitis (UC).SKYRIZI is targ...
26 July 2024 - Swedish biopharma company Calliditas Therapeutics AB (STO:CALTX) on Friday reported positive topline data from its Phase 2b TRANSFORM trial evaluating setanaxib, a NOX enzyme inhibitor, in patients with primary biliary cholangitis (PBC...
26 July 2024 - Clinical-stage biotechnology company Cellectis (Euronext Growth Paris:ALCLS) (NASDAQ:CLLS) announced on Thursday that the US Food and Drug Administration (FDA) has granted Orphan Drug and Rare Pediatric Disease Designation for its UCAR...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe